You're reading the free version. Trader adds the live tape and alerts.
Start tracking
APVO Exercise Disclosure
Lamothe Jeffrey G. · SEC Form 4 · Filed Aug 10, 2026
Exercise
Reported value range
Not reported
Lamothe Jeffrey G. President And CEO
APVO
Transaction date
Aug 6, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 4 days later
APVO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 961 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-343079
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aptevo Therapeutics Inc. APVO | Exercise | Aug 6, 2026 | $0 |
| Aptevo Therapeutics Inc. APVO Current | Exercise | Aug 6, 2026 | Not reported |